RNU7-169P

Across TCGA pan-cancer cohorts, RNU7-169P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU7-169P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU7-169P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-169P expression acts as an unfavorable survival marker.

BLCA, THCA, and SKCM are the cancer types where RNU7-169P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	II,III,IV	0.204	0.713	<.001	144	view →
THCA	DFS	Tertile	All	0.471	0.847	.005	36	view →
SKCM	OS	Tertile	All	0.514	0.880	<.001	30	view →
PCPG	OS	Tertile	All	0.531	0.848	<.001	27	view →
COAD	DFS	Tertile	IV	0.035	0.501	<.001	18	view →
KICH	DFS	Tertile	All	0.425	0.847	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU7-169P–BLCA (OS)

Open the BLCA breakdown →